Intranasal Corticosteroids Market Share

  • Report ID: 4173
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Intranasal Corticosteroids Market Share

Regionally, the global intranasal corticosteroids market is studied into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Asia Pacific industry is predicted to account for largest revenue share by 2037, on account of higher prevalence of type 1 diabetes, rheumatoid arthritis, and other types of scleros. China and India are the countries with a skyrocketing prevalence of type 1 diabetes since half of the total diabetes patients in the Asia Pacific are living in these two countries. Based on the data provided by the International Diabetes Federation in 2021, it was stated that 90 million people have diabetes in South-East Asia while the figure is further expected to reach 152 million over the forecast period.  Hence, the market is anticipated to grow at a significant pace over the forecast period in the Asia Pacific Region.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4173
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of intranasal corticosteroids is estimated at USD 7.44 billion.

Intranasal Corticosteroids Market size was valued at USD 7.13 billion in 2024 and is likely to cross USD 13.61 billion by 2037, registering more than 5.1% CAGR during the forecast period i.e., between 2025-2037.

Asia Pacific industry is predicted to account for largest revenue share by 2037, on account of higher prevalence of type 1 diabetes, rheumatoid arthritis, and other types of sclerosis.

The major players in the market are AstraZeneca PLC, Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., GSK plc, Sanofi S.A., Ivax Pharmaceuticals, Inc., OptiNose US, Inc., Chattem Chemicals, Inc., and Intersect ENT Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample